bpc 157 fda warning 2024 2025 Banned: Key Facts on the Latest Decision BPC-157 FDA Approval Status: Is
Description
Those With Bleeding Disorders: Animal studies suggesting enhanced blood vessel formation and circulation effects warrant caution in individuals with bleeding disorders or taking anticoagulant medications
May cause false elevations in urobilinogen tests 4
Every vial carries a batch number matching the COA
Drew Timmermans, ND, a naturopathic physician and cofounder of Regenerative Performance in Arizona, notes the limited but encouraging research
As always, patients are advised not to start or stop any other prescription drug, over-the-counter product, or supplement without consulting their healthcare provider during sermorelin therapy
[DOI] [PubMed] [Google Scholar] Kang, E
